Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)

NSE:SANOFICONR Income Statement

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	6,755	7,245	8,331
Revenue Growth (YoY)	-	-13.04%	-
Cost of Revenue	1,665	1,877	2,291
Gross Profit	5,090	5,368	6,041
Selling, General & Admin	1,302	1,235	1,050
Other Operating Expenses	1,260	1,427	1,709
Operating Expenses	2,618	2,707	2,786
Operating Income	2,472	2,661	3,255
Interest Expense	-43	-39	-
Interest & Investment Income	118	118	60
Currency Exchange Gain (Loss)	1	1	-
Other Non Operating Income (Expenses)	33	11	1.5
EBT Excluding Unusual Items	2,581	2,752	3,317
Asset Writedown	-29	-29	-
Other Unusual Items	-255	-255	-27
Pretax Income	2,297	2,468	3,290
Income Tax Expense	614	658	816
Net Income	1,683	1,810	2,474
Net Income to Common	1,683	1,810	2,474
Net Income Growth	-	-26.82%	-
Shares Outstanding (Basic)	21	23	23
Shares Outstanding (Diluted)	21	23	23
EPS (Basic)	81.50	78.59	107.40
EPS (Diluted)	81.50	78.59	107.40
EPS Growth	-	-26.82%	-
Free Cash Flow	-	4,291	-66
Free Cash Flow Per Share	-	186.32	-2.87
Dividend Per Share	-	55.000	-
Gross Margin	75.35%	74.09%	72.51%
Operating Margin	36.59%	36.73%	39.07%
Profit Margin	24.92%	24.98%	29.69%
Free Cash Flow Margin	-	59.23%	-0.79%
EBITDA	2,493	2,683	3,282
EBITDA Margin	36.90%	37.03%	39.40%
D&A For EBITDA	20.75	22	27
EBIT	2,472	2,661	3,255
EBIT Margin	36.59%	36.73%	39.07%
Effective Tax Rate	26.73%	26.66%	24.81%
Revenue as Reported	6,907	7,375	8,393
Advertising Expenses	-	181	-

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.